Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre for Immunology & Infection (C2i) is a major research initiative located in the Hong Kong Science Park, established as a collaboration between the University of Hong Kong (HKU) and the Institut Pasteur. Operating under the InnoHK initiative, C2i focuses on developing innovative solutions for the characterization of immune responses to infectious agents and the development of new diagnostic and therapeutic strategies. The center's work spans four main pillars: healthy immune profiling in the Asian population, precision medicine for infectious diseases, respiratory virus epidemiology, and the development of novel vaccine platforms. By leveraging high-throughput technologies and advanced immunology, C2i aims to transform the management of infectious diseases and enhance pandemic preparedness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Immunology & Infection.